Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Ulrich Burger

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Pharmaceutical Statistics|March 27, 2019
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17(5):593-606, Sep/Oct 2018. DOI: 10.1002/pst.1873Hans Ulrich Burger
Pharmaceutical Statistics|July 22, 2016
Bayesian predictive power: choice of prior and some recommendations for its use as probability of success in drug developmentKaspar Rufibach, Hans Ulrich Burger, Markus Abt
BMC Medical Research Methodology|July 14, 2016
Statistical guidance for responsible data sharing: an overviewChristine Fletcher, Sally Hollis, Hans-Ulrich Burger, et al.
Therapeutic Innovation & Regulatory Science|April 14, 2025
Futility Interim Analyses - A Plea for SimplicityGian-Andrea Thanei, Gaëlle Klingelschmitt, Claude Berge, et al.
Biometrical Journal. Biometrische Zeitschrift|June 28, 2016
Comparison of design strategies for a three-arm clinical trial with time-to-event endpoint: Power, time-to-analysis, and operational aspectsElina Asikanius, Kaspar Rufibach, Jasmin Bahlo, et al.
Biometrical Journal. Biometrische Zeitschrift|July 17, 2019
A multistate model for early decision-making in oncologyUlrich Beyer, David Dejardin, Matthias Meller, et al.
Pharmaceutical Statistics|October 19, 2013
European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial dataChristine Fletcher, Stefan Driessen, Hans Ulrich Burger, et al.
Journal of Biopharmaceutical Statistics|April 1, 2024
Estimating treatment effect in randomized trial after control to treatment crossover using external controlsXiner Zhou, Herbert Pang, Christiana Drake, et al.
Supportive Cancer Therapy|July 18, 2008
Effect of treatment with epoetin Beta on thromboembolic events in anemic patients with cancer: a metaanalysisBertrand Coiffier, Marc Boogaerts, Matti Aapro, et al.
Biometrical Journal. Biometrische Zeitschrift|September 17, 2025
From Data to Knowledge. Advancing Life Sciences: Editorial for the CEN2023 Special IssueWerner Brannath, Frank Bretz, Hans Ulrich Burger, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|March 27, 2019
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17(5):593-606, Sep/Oct 2018. DOI: 10.1002/pst.1873Hans Ulrich Burger
Pharmaceutical Statistics|July 22, 2016
Bayesian predictive power: choice of prior and some recommendations for its use as probability of success in drug developmentKaspar Rufibach, Hans Ulrich Burger, Markus Abt
BMC Medical Research Methodology|July 14, 2016
Statistical guidance for responsible data sharing: an overviewChristine Fletcher, Sally Hollis, Hans-Ulrich Burger, et al.
Therapeutic Innovation & Regulatory Science|April 14, 2025
Futility Interim Analyses - A Plea for SimplicityGian-Andrea Thanei, Gaëlle Klingelschmitt, Claude Berge, et al.
Biometrical Journal. Biometrische Zeitschrift|June 28, 2016
Comparison of design strategies for a three-arm clinical trial with time-to-event endpoint: Power, time-to-analysis, and operational aspectsElina Asikanius, Kaspar Rufibach, Jasmin Bahlo, et al.
Biometrical Journal. Biometrische Zeitschrift|July 17, 2019
A multistate model for early decision-making in oncologyUlrich Beyer, David Dejardin, Matthias Meller, et al.
Pharmaceutical Statistics|October 19, 2013
European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial dataChristine Fletcher, Stefan Driessen, Hans Ulrich Burger, et al.
Journal of Biopharmaceutical Statistics|April 1, 2024
Estimating treatment effect in randomized trial after control to treatment crossover using external controlsXiner Zhou, Herbert Pang, Christiana Drake, et al.
Supportive Cancer Therapy|July 18, 2008
Effect of treatment with epoetin Beta on thromboembolic events in anemic patients with cancer: a metaanalysisBertrand Coiffier, Marc Boogaerts, Matti Aapro, et al.
Biometrical Journal. Biometrische Zeitschrift|September 17, 2025
From Data to Knowledge. Advancing Life Sciences: Editorial for the CEN2023 Special IssueWerner Brannath, Frank Bretz, Hans Ulrich Burger, et al.
Pageof 3